Scientific state: OBSERVED ≠ CANDIDATE ≠ AI_PREREVIEWED ≠ HI_REVIEWED ≠ VALIDATED ≠ PROPOSED. Read the integrity legend →
iSydney · Digital CIDM · Colleague Beta
Digital CIDM
v1.6
A former dream becomes an inspectable prototype

Digital CIDM · Alpha

This Digital CIDM page preserves the legacy 2,231-record discovery graph with stable City IDs and source-derived links. It is a historical discovery layer, not the current unique-work denominator. The current publication checkpoint contains 1,947 auditable unique publication objects.

Important: the source itself is an author-search-derived PubMed master. Digital CIDM therefore preserves the explicit warning that affiliation validation is still needed before treating every record as a definitive institutional output.
Colleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.
2,231legacy discovery records
8,061source-derived typed links
504journal objects
99theme objects
23specified pathogen groups
Explorer

Open the current 1,947 unique-work Explorer

Search by title, authors, PMID, DOI, year, theme, pathogen and technology, then open a publication Passport.

Objects

Stable CPD identities

Each retained 1995–2026 publication receives a stable Digital CIDM ID from CPD-0001 to CPD-2231.

Relationships

Evidence-aware roads

Workbook classifications generate Explorer-visible links. They are not silently promoted to fully trusted institutional claims.

Top source-derived signals

Themes

Clinical microbiology / infectious diseases — 657
COVID-19 / respiratory viruses — 194
Diagnostics / laboratory methods — 136
Clinical infectious diseases — 128
Medical mycology — 112

Pathogens

Influenza / respiratory viruses — 119
SARS-CoV-2 — 113
Cryptococcus — 97
Candida / Candidozyma — 81
Staphylococcus aureus / MRSA — 54

Technologies

Culture / phenotypic methods — 451
Clinical trial / therapy — 146
Whole-genome sequencing; Culture / phenotypic methods — 120
Serology / immunology — 86
PCR / molecular diagnostics — 72